Skip to main content

Xenon (XENE) Receives a Buy from J.P. Morgan

Tipranks - Tipranks - Wed Jan 21, 6:40AM CST

J.P. Morgan analyst Tessa Romero maintained a Buy rating on Xenon today and set a price target of $62.00.

Claim 50% Off TipRanks Premium

Romero covers the Healthcare sector, focusing on stocks such as Agios Pharma, Xenon, and Cytokinetics. According to TipRanks, Romero has an average return of 24.1% and a 55.36% success rate on recommended stocks.

In addition to J.P. Morgan, Xenon also received a Buy from William Blair’s Myles Minter in a report issued on January 13. However, on January 15, TipRanks – Google initiated coverage with a Hold rating on Xenon (NASDAQ: XENE).

See Insiders’ Hot Stocks on TipRanks >>

Based on Xenon’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $90.9 million. In comparison, last year the company had a GAAP net loss of $62.79 million

Read More on XENE:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).